NCT02080494

Tranexamic Acid in Orthopaedic Trauma Surgery

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 101 (actual)
• Sponsor: University of Tennessee · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Tranexamic acid is an antifibrinolytic drug that has been used to decrease post-operative blood loss. This study is a prospective, randomized controlled trial investigating the use of tranexamic acid in fracture surgery around the hip and knee, in which significant blood loss (\>300mL) is expected. The hypothesis of this study is that tranexamic acid will be associated with a decrease in post-operative blood loss, as well as a decreased need for allogenic blood transfusion, in patients who have fracture surgery around the hip and knee.

Conditions

• Blood Loss
• Trauma
• Fracture
• Surgery

Interventions

Type	Name	Description
DRUG	Tranexamic Acid

Timeline

• Start date: 2012-05-01
• Primary completion: 2018-12-01
• Completion: 2018-12-01
• First posted: 2014-03-06
• Last updated: 2018-07-11

Locations

1 site across 1 country: United States